Skip to content
Screener

Goodwill at other companies

Myriad Genetics logo
Myriad GeneticsMYGN
$47.1M-83.5%
Labcorp Holdings logo
Labcorp HoldingsLH
$7.03B+7.3%
Quest Diagnostics logo
Quest DiagnosticsDGX
$9.11B+2.6%
Biodesix, Inc. logo
Biodesix, Inc.BDSX
$15.03M0.0%
Guardant Health logo
Guardant HealthGH
$77.26M+2,248%
Natera, Inc. logo
Natera, Inc.NTRA
$141.1M

Other financials

Income statement

See full
Revenue$201.7M+11.2%
Gross profit$91.9M+18.9%
Operating income-$9.8M+79.5%
Net income$2.2M+105%
EPS (diluted)$0.02+106%

Balance sheet

See full
Cash & equivalents$145.5M-5.9%
Total debt$448.4M+534%
Total equity$785.7M-8.0%
Total assets$1.4B-3.0%

Cash flow

See full
Operating cash flow$20.0M-1.8%
CapEx$8.2M+30.0%
Free cash flow-$13.1M+56.0%

Valuation

See full
Market cap$2.13B+183%
Enterprise value$2.43B+264%
P/S2.8×+1.7×

Profitability

See full
Gross margin43.9%0.0pp
Operating margin-8.9%-2.8pp
Net margin-6.8%-2.4pp
FCF margin-4.9%

Returns & leverage

See full
Return on equity-6.3%-2.0pp
Debt / equity0.6×+0.5×
Current ratio3.6×-0.3×

Where this comes from

Reported directly by NeoGenomics in its filing.

Tagged under the XBRL concept us-gaap:Goodwill.

The source filing: NeoGenomics’s 10-Q, filed July 28, 2026.

Filed
Jul 28, 2026, 4:09 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001077183-26-000059
Line item(unaudited)June 30, 2026December 31, 2025
Operating lease right-of-use assets78,60678,444
Financing lease right-of-use assets6,65354
Intangible assets, net271,262286,528
Goodwill523,995524,344
Other assets9,3119,340
Total non-current assets970,765983,544
Total assets$1,352,243$1,359,830
LIABILITIES AND STOCKHOLDERS’ EQUITY

Item 1. Financial Statements (unaudited)

FAQ

What is NeoGenomics's goodwill?
NeoGenomics (NEO) reported goodwill of $524M in Q2 2026.
How has NeoGenomics's goodwill changed year-over-year?
NeoGenomics's goodwill decreased by 0.0% year-over-year, from $524.14M to $524M.
What is the long-term trend for NeoGenomics's goodwill?
Over 5 years (2020 to 2025), NeoGenomics's goodwill has grown at a 20.0% compound annual growth rate (CAGR), from $211.08M to $524.34M.
What does goodwill mean?
The excess of acquisition cost over the fair value of net identifiable assets acquired — representing brand value, customer relationships, and synergies from past M&A.

Ask your AI about NeoGenomics's goodwill.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude